These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27466500)

  • 1. Evaluation of Global Histone Acetylation Levels in Bladder Cancer Patients.
    Ellinger J; Schneider AC; Bachmann A; Kristiansen G; Müller SC; Rogenhofer S
    Anticancer Res; 2016 Aug; 36(8):3961-4. PubMed ID: 27466500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer.
    Ellinger J; Bachmann A; Göke F; Behbahani TE; Baumann C; Heukamp LC; Rogenhofer S; Müller SC
    Urol Int; 2014; 93(1):113-8. PubMed ID: 24556868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma.
    Mosashvilli D; Kahl P; Mertens C; Holzapfel S; Rogenhofer S; Hauser S; Büttner R; Von Ruecker A; Müller SC; Ellinger J
    Cancer Sci; 2010 Dec; 101(12):2664-9. PubMed ID: 20825416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
    Damodaran S; Damaschke N; Gawdzik J; Yang B; Shi C; Allen GO; Huang W; Denu J; Jarrard D
    BMC Cancer; 2017 Dec; 17(1):874. PubMed ID: 29262808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
    I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global levels of histone modifications predict prostate cancer recurrence.
    Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
    Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer.
    Schneider AC; Heukamp LC; Rogenhofer S; Fechner G; Bastian PJ; von Ruecker A; Müller SC; Ellinger J
    BJU Int; 2011 Oct; 108(8 Pt 2):E290-6. PubMed ID: 21627749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global histone modification patterns predict risk of prostate cancer recurrence.
    Seligson DB; Horvath S; Shi T; Yu H; Tze S; Grunstein M; Kurdistani SK
    Nature; 2005 Jun; 435(7046):1262-6. PubMed ID: 15988529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
    Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
    Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
    Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
    Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
    Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease.
    Kocic G; Cukuranovic J; Stoimenov TJ; Cukuranovic R; Djordjevic V; Bogdanovic D; Stefanovic V
    Ren Fail; 2014 Aug; 36(7):1078-82. PubMed ID: 24845033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
    Denzinger S; Stoehr R; Schwarz S; Eichenseher N; Brockhoff G; Obermann EC; Knuechel R; Blaszyk H; Hartmann A; Wild PJ
    Int J Oncol; 2007 Oct; 31(4):793-802. PubMed ID: 17786310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential.
    Barbisan F; Mazzucchelli R; Santinelli A; Stramazzotti D; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2008; 21(3):615-23. PubMed ID: 18831929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.
    Hofner T; Macher-Goeppinger S; Klein C; Schillert A; Eisen C; Wagner S; Rigo-Watermeier T; Baccelli I; Vogel V; Trumpp A; Sprick MR
    Urol Oncol; 2014 Jul; 32(5):678-86. PubMed ID: 24631171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
    Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
    Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
    Song JS; Kim YS; Kim DK; Park SI; Jang SJ
    Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
    Elsheikh SE; Green AR; Rakha EA; Powe DG; Ahmed RA; Collins HM; Soria D; Garibaldi JM; Paish CE; Ammar AA; Grainge MJ; Ball GR; Abdelghany MK; Martinez-Pomares L; Heery DM; Ellis IO
    Cancer Res; 2009 May; 69(9):3802-9. PubMed ID: 19366799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.